Clinical trial / 2008
Saffron supplementation relieved symptoms of premenstrual syndrome and improved depression scores in a randomized controlled trial.
A double-blind, randomized, placebo-controlled trial evaluated whether saffron (30 mg/day; 15 mg twice a day) relieved premenstrual syndrome (PMS) symptoms compared to placebo across two menstrual cycles (cycles 3 and 4) in women aged 20-45 years. Saffron was found to be effective in relieving PMS symptoms. A significant difference was observed in efficacy of saffron in cycles 3 and 4 in the Total Premenstrual Daily Symptoms and the Hamilton Depression Rating Scale.
- Study type
- Double-blind, randomised and placebo-controlled trial
- Who was studied
- Women aged 20-45 years with regular menstrual cycles and PMS symptoms for >= 6 months
- What was measured
- Daily Symptom Report and Hamilton Depression Rating Scale
THE PAPER
Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.
Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, Akhondzadeh S. BJOG, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.